SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-06-001307
Filing Date
2006-05-11
Accepted
2006-05-11 14:41:14
Documents
4
Period of Report
2006-05-11

Document Format Files

Seq Description Document Type Size
1 5/11/06 sks307a.htm 6-K 151479
2 GRAPHIC ballot.jpg GRAPHIC 751
3 GRAPHIC computershare.gif GRAPHIC 1478
4 GRAPHIC nymox-graph.gif GRAPHIC 4788
  Complete submission text file 0000897069-06-001307.txt   163028
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 06829559
SIC: 2835 In Vitro & In Vivo Diagnostic Substances